Sherri joined AstraZeneca in March 2018 as Senior Director of Device Development. She is responsible for parenterals device development across AZ including technology innovation, development and scale-up for commercial manufacturing. Currently, her department is developing a range of products including injection devices, transfer device and connected drug delivery systems that enable patient monitoring and data collection. Prior to working at Astra Zeneca, Sherri was Director of Device Development at Genentech and Director of Product Development at Alexza Pharmaceuticals developing both injection and inhalation products.
Sessions
A1: Q&A for Integrated Device Development/Holistic Development Strategies